Screener
KCE vs XPH
State Street SPDR S&P Capital Markets ETF vs State Street SPDR S&P Pharmaceuticals ETF
Key differences
- Over the last 3 years, KCE has delivered higher annualized returns.
Side-by-side comparison
| KCE | XPH | |
|---|---|---|
| Annual cost (TER) | 0.35% | 0.35% |
| Fund size (AUM) | $456M | $355M |
| Since | 2005 | 2006 |
| Dividend yield | 1.70% | 0.65% |
| Asset class | equity | equity |
| Region | north america | north america |
| Strategy | index tracking | index tracking |
| CAGR 1Y | +15.1% | +46.3% |
| CAGR 3Y | +26.5% | +13.8% |
| CAGR 5Y | +12.9% | +4.5% |
| Sharpe 3Y | 1.05 | 0.57 |
| Volatility 1Y | 19.67% | 21.29% |
| Max drawdown | -40.78% | -35.96% |
Green dot indicates the better value for that metric. Performance data is historical and does not predict future results.
Similar to KCE and XPH
Explore further